A randomized study in 58 men with limited metastatic prostate cancer found that PSMA therapy postponed the need for hormone ...

Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...

The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...

PDS Biotechnology Corporation has reported a successful fourth quarter of 2025, marked by significant progress across its clinical programs. The company's management team, comprising Dr. Frank ...

Foley, was diagnosed with Stage 2 breast cancer in October. She owed her diagnosis to a secondary screening, similar to an ultrasound, biopsy or other diagnostic test. Now, ...

The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Dr. William Maguire discussing regulatory considerations related to PSMA PET imaging in clinical trials.

The trial design for ARASTEP is highlighted in the following schema: Two special considerations for ARASTEP are that all patients have maximally treated pelvic disease and that metastasis directed ...

Transdermal estradiol offers fewer hot flashes and lower fracture rates, but higher rates of gynecomastia, as it meets the ...

Top cancer specialists are urging men to look past the common symptoms of aging and recognize these critical warning signs.

Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...